Market Tracker

01/19 5:16pm ET

Cascadian Therapeutics Inc (NASDAQ:CASC)

3.77
Delayed Data
As of 4:00pm ET
 -0.275 / -6.80%
Today’s Change
3.72
Today|||52-Week Range
10.98
-12.53%
Year-to-Date
No recent news for Cascadian Therapeutics Inc.

Today’s Trading

Previous close4.05
Today’s open4.03
Day’s range3.72 - 4.10
Volume245,059
Average volume (3 months)175,819
Market cap$91.2M
Dividend yield--
Data as of 4:00pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)+46.88%
Earnings growth (this year)-61.76%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.59

Competitors

 Today’s
change
Today’s
% change
BCLIBrainstorm Cell Ther...-0.06-2.21%
RKDAArcadia Biosciences ...+0.02+1.90%
ARWRArrowhead Pharmaceut...-0.12-6.12%
PRTOProteon Therapeutics...+0.05+2.63%
Data as of 4:00pm ET, 01/19/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$0.00
Annual profit (last year)-$32.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts